---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-077725"
form_type: "8-K"
ticker: "CC"
cik: "0001627223"
company_name: "Chemours Co"
filed_at: "2024-03-26T23:59:59+00:00"
generated_at: "2026-06-04T07:53:46.672363+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Chemours schedules Q4/FY23 earnings release for March 27, conference call March 28

## Summary
- Expects to issue Q4 and full-year 2023 financial results after market close on March 27, 2024.
- Annual Report on Form 10-K for year ended December 31, 2023 also to be filed March 27.
- Conference call to discuss results at 8:00 a.m. EDT on March 28, 2024; webcast on investors.chemours.com.
- Interim CFO Matthew Abbott signed the filing; no financial results disclosed in this 8-K.

## SEC filing metadata
- accession: 0001193125-24-077725
- form_type: 8-K
- ticker: CC
- cik: 0001627223
- company_name: Chemours Co
- filed_at: 2024-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/0001193125-24-077725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/d782971d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-077725
- JSON: https://secwatch.observer/filing/0001193125-24-077725.json
- Plain text: https://secwatch.observer/filing/0001193125-24-077725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.